DARE BIOSCIENCE INC
DARE · NASDAQ
Updated at 2026-10-13 11:51:56
- Today's High
- --
- Today’s Low
- --
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $0.77
- Previous Close
- $0.75
- Volume
- 81.97K
- Market Cap
- $14.75M
- P/E Ratio
- --
- EPS
- $-0.78
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Pharmaceuticals
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 3655 NOBEL DRIVE, SAN DIEGO, CA, UNITED STATES, 92122
- Country
- US
- Listing Date
- 2014-04-10
- Fiscal Year End
- December
- Shares Outstanding
- 14.98M
- CIK
- 0001401914
- Website
- www.darebioscience.com
Dar Bioscience, Inc., a clinical-stage biopharmaceutical company, focuses on developing and marketing women's health products in the United States. The company is headquartered in San Diego, California.
Financial Metrics
Revenue
2026-06-30
$187.54K
2026-03-31
$152.45K
2025-12-31
$1.02M
2025-09-30
$2.26K
Operating Expenses
2026-06-30
$2.83M
2026-03-31
$2.35M
2025-12-31
$2.19M
2025-09-30
$2.49M
Net Income
2026-06-30
-$2.98M
2026-03-31
-$2.99M
2025-12-31
-$1.44M
2025-09-30
-$3.56M
Net Profit Margin
2026-06-30
-1.59K%
2026-03-31
-1.96K%
2025-12-31
-140.83%
2025-09-30
-157.5K%
Earnings Per Share
2026-06-30
$-0.20
2026-03-31
$-0.20
2025-12-31
$-0.10
2025-09-30
$-0.28
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$2.38M
2026-03-31
-$2.24M
2025-12-31
-$907.32K
2025-09-30
-$3.08M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $187.54K | $152.45K | $1.02M | $2.26K |
| Operating Expenses | $2.83M | $2.35M | $2.19M | $2.49M |
| Net Income | -$2.98M | -$2.99M | -$1.44M | -$3.56M |
| Net Profit Margin | -1.59K% | -1.96K% | -140.83% | -157.5K% |
| Earnings Per Share | $-0.20 | $-0.20 | $-0.10 | $-0.28 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$2.38M | -$2.24M | -$907.32K | -$3.08M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.